Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.69 EUR | -0.80% | +1.05% | +12.27% |
Apr. 26 | Transcript : Terveystalo Oyj, Q1 2024 Earnings Call, Apr 26, 2024 | |
Apr. 26 | Terveystalo Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.27% | 1.19B | B- | ||
-16.43% | 17.21B | B+ | ||
+5.41% | 12.54B | B | ||
+4.64% | 11.71B | B+ | ||
+3.44% | 10.43B | B+ | ||
+28.72% | 8.51B | B | ||
-1.92% | 7.74B | A- | ||
+21.65% | 7.18B | D | ||
+5.12% | 6.55B | B- | ||
+46.09% | 4.5B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TTALO Stock
- Ratings Terveystalo Oyj